Skip to content

The Effects of Mindfulness-Based Stress Reduction and Stress Management Education on Arterial Stiffness, Trait Anxiety, and Sympathetic Regulation

Grant Thivierge, Aditi Vyas, Brigitte Morin, Robert Larson, John Durocher

Physiology May 1, 2023 DOI: 10.1152/physiol.2023.38.s1.5795525 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 22
Population Adults aged about 25 years with elevated blood pressure (≥120/80 mmHg); 17 male, 5 female; mean BMI 26 kg/m2
Interventions Mindfulness-based stress reduction (MBSR) stress management education (SME)
Duration 8-week intervention; measurements within 10 days before and after
Measures carotid-femoral pulse wave velocity (cfPWV), muscle sympathetic nerve activity (MSNA) burst frequency, trait anxiety
Topics Anxiety Meditation
Key findings MBSR reduced heart rate (77 to 69 beats/min) and trait anxiety decreased over time (38 to 34), while mean arterial blood pressure, arterial stiffness (cfPWV 5.6 to 5.4 m/s), and muscle sympathetic nerve activity did not change with either MBSR or SME. The authors suggest MBSR may have benefits for heart rate and anxiety but not for arterial stiffness or resting MSNA in this population.

Abstract

Mindfulness-based stress reduction (MBSR) has been shown to reduce blood pressure and anxiety in several studies, but the effects of MBSR on arterial stiffness and muscle sympathetic nerve activity (MSNA) have not been studied. We hypothesized that MBSR would lower arterial stiffness and MSNA. The present study randomized 22 adults (17 male; 5 female; age 25±1 years; BMI 26±1 kg/m2) with elevated blood pressure (i.e., ≥120/80 mmHg) into 8 weeks of MBSR or stress management education (SME). We examined resting blood pressure, heart rate, trait anxiety, arterial stiffness, and MSNA within 10 days before and after each of the 8-week interventions. Ten participants were randomized into the MBSR group, and 12 into the SME group. Resting blood pressure and heart rate were recorded as the average of three readings from an automated cuff in the seated position. Arterial stiffness was estimated as the average of two carotid-femoral pulse wave velocity (cfPWV) recordings in the supine position, and MSNA was recorded as burst frequency via direct post-ganglionic recordings from the peroneal nerve in a subset of participants. Mean arterial blood pressure was unchanged from pre- to post in either group, but heart rate was reduced from pre- to post in the MBSR participants (77±4 vs. 69±3 beats/min; p=0.01). There was a significant time-effect for trait anxiety, with raw scores reduced from pre- to post (38±3 vs. 34±2 a.u.; p=0.02). cfPWV was unchanged from pre to post (5.6±0.2 vs. 5.4±0.2 m/s; p=0.25), and MSNA was also unchanged (time-effect p=0.51) by MBSR (14±2 vs. 12±3 bursts/min; n=5) or SME (16±1 vs. 15±2 bursts/min; n=5). Results of the present study confirm that MBSR can have beneficial effects such as reducing HR and trait anxiety. Our results suggest that MBSR and SME do not change arterial stiffness or resting MSNA, but this may deserve further investigation in other at-risk populations. NIH (1R15HL140596-01) This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics